WaveMan · Form 4
Gengos Andrew insider trades
> Search tickers & screens ⌘K
LIVE

Gengos Andrew insider trades

Gengos Andrew has filed 16 Form 4s with the SEC that we hold, for LeonaBio, Inc. (ATHA) (CFO and Chief Business Officer), TERN (Chief Financial Officer), Turn Therapeutics Inc. (TTRX) (Director) and CYT (Chief Business Officer), among 5 companies in all. Across all of them we count 13 purchases worth $289.8K and 3 sales worth $7.8K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 15,000 shares of LeonaBio, Inc. worth $45.0K, dated 2023-06-05. The first filing on our record is dated 2022-02-24 and the latest 2026-07-17.

LeonaBio, Inc. (ATHA)

CFO and Chief Business Officer · 7 filings · 12 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-01-05S, sale reported on Form 41,208$3.5K2024-01-08
2023-06-02P, purchase reported on Form 410,012$27.5K2023-06-06
2023-06-02P, purchase reported on Form 46,582$18.8K2023-06-06
2023-06-02P, purchase reported on Form 43,418$10.1K2023-06-06
2023-06-05P, purchase reported on Form 410,000$30.2K2023-06-06
2023-06-05P, purchase reported on Form 410,000$30.0K2023-06-06
2023-06-05P, purchase reported on Form 415,000$45.0K2023-06-06
2023-06-07P, purchase reported on Form 411,719$40.3K2023-06-09
2023-06-07P, purchase reported on Form 4422$1.4K2023-06-09
2023-06-07P, purchase reported on Form 42,859$9.7K2023-06-09
2024-01-05S, sale reported on Form 41,208$3.5K2024-02-16
2024-09-05S, sale reported on Form 41,272$7252024-09-05

TERN

Chief Financial Officer · 5 filings · 4 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-06-13P, purchase reported on Form 45,000$18.8K2025-06-16
2025-06-13P, purchase reported on Form 45,000$18.6K2025-06-16
2025-06-16P, purchase reported on Form 45,000$19.8K2025-06-16
2025-06-27P, purchase reported on Form 45,000$19.6K2025-06-30

Turn Therapeutics Inc. (TTRX)

Director · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

CYT

Chief Business Officer · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Immuneering Corp (IMRX)

Chief Financial Officer · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1563623) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms